Glycine- and proline-rich glycoprotein regulates the balance between cell proliferation and apoptosis for ACF formation in 1,2-dimethylhydrazine-treated A/J mice

Molecular and Cellular Biochemistry

Volumn 325, Issue 1-2, 2009, Pages 187-197

  Lee, Sei Jung ^a   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

Aberrant crypt foci; Apoptosis; Cell proliferation; Colon carcinogenesis; SNL glycoprotein

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; CYCLOOXYGENASE 2; GLYCINE AND PROLINE RICH GLYCOPROTEIN; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR FACTOR KAPPA B P50 SUBUNIT; PROCASPASE 3; PROTEIN P53; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

A J MOUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; INTESTINE CRYPT; MALE; MOUSE; NONHUMAN; SOLANUM NIGRUM;

MUS; SOLANUM NIGRUM;

EID: 64249112551     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0033-5     Document Type: Article

References (52)

1. Greenwald P, Kelloff GJ, Boone CW, McDonald SS (1995) Genetic and cellular changes in colorectal cancer: Proposed targets of chemopreventive agents. Cancer Epidemiol Biomarkers Prev 4:691-702
2. Sharma RA, Manson MM, Gescher A, Steward WP (2001) Colorectal cancer chemoprevention: Biochemical targets and clinical development of promising agents. Eur J Cancer 37:12-22. doi: 10.1016/ S0959-8049(00)00326-9
3. Mori H, Sugie S, Yoshimi N, Hara A, Tanaka T (1999) Control of cell proliferation in cancer prevention. Mutat Res 428:291-298. doi: 10.1016/ S1383-5742(99)00055-1
4. Aranha MM, Borralho PM, Ravasco P, Moreira da Silva IB, Correia L, Fernandes A, Camilo ME, Rodrigues CM (2007) NF-kappaB and apoptosis in colorectal tumourigenesis. Eur J Clin Invest 37:416-424. doi: 10.1111/ j.1365-2362.2007.01801.x
5. Leonard SS, Harris GK, Shi X (2004) Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 37:1921-1942. doi: 10.1016/ j.freeradbiomed.2004.09.010
6. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis - the p53 network. J Cell Sci 116:4077-4085. doi: 10.1242/jcs.00739
7. Ma Q, Hoper M, Anderson N, Rowlands BJ (1996) Effect of supplemental l -arginine in a chemical-induced model of colorectal cancer. World J Surg 20:1087-1091. doi: 10.1007/s002689900165
8. McLellan EA, Bird RP (1988) Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res 48:6187-6192
9. Shpitz B, Hay K, Medline A, Bruce WR, Vivona A, Gallinger S, Bull S, Stern N (1993) Aberrant crypt foci: Early markers of malignancy in rat colon carcinogenesis. Proc Am Assoc Cancer Res 34:A684
10. Ooi VE, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7:715-729
11. Lee SJ, Oh PS, Ko JH, Lim K, Lim KT (2004) A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells. Cancer Chemother Pharmacol 54:562-572. doi: 10.1007/s00280-004-0850-x
12. Lee SJ, Lim KT (2006) 150 kDa glycoprotein isolated from Solanum nigrum Linne stimulates caspase-3 activation and reduces inducible nitric oxide production in HCT-116 cells. Toxicol In Vitro 20:1088-1097. doi: 10.1016/ j.tiv.2006.01.019
13. Lim KT, Heo KS, Son YO (2002) Antioxidative and antimicrobial effects of glycoprotein isolated from Solanum nigrum Linne. Food Sci Biotechnol 11:484-489
14. Lee SJ, Lim KT (2003) Antioxidative effects of glycoprotein isolated from Solanum nigrum Linne on oxygen radicals and its cytotoxic effects on the MCF-7 cells. J Food Sci 68:466-470. doi: 10.1111/ j.1365-2621.2003.tb05695.x
15. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 37:147-151. doi: 10.1016/0304-3835(87)90157-1
16. Bird RP, Good CK (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112-113:395-402. doi: 10.1016/S0378-4274(99)00261-1
17. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310. doi: 10.1016/S0076-6879(78)52032-6
18. 15N] nitrate in biological fluids. Anal Biochem 126:131-138. doi: 10.1016/ 0003-2697(82)90118-X
19. Bergmeyer HU, Bernt E (1974) Lactate dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 574-579
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
21. Lee BM, Park KK (2003) Beneficial and adverse effects of chemopreventive agents. Mutat Res 523-524:265-278. doi: 10.1016/S0027-5107(02)00342-1
22. Sengupta A, Ghosh S, Das RK, Bhattacharjee S, Bhattacharya S (2006) Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways. Eur J Cancer Prev 15:301-305. doi: 10.1097/ 00008469-200608000-00005
23. Ferguson LR, Harris PJ (1999) Protection against cancer by wheat bran: role of dietary fibre and phytochemicals. Eur J Cancer Prev 8:17-25. doi: 10.1097/00008469-199902000-00003
24. Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB (2000) In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des 15:151-160
25. Zhang WM, Lai ZS, He MR, Xu G, Huang W, Zhou DY (2003) Effects of the antibacterial peptide cecropins from Chinese oak silkworm, Antheraea pernyi on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Di Yi Jun Yi Da Xue Xue Bao 23:1066-1068
26. Otvos L Jr (2000) Antibacterial peptides isolated from insects. J Pept Sci 6:497-511. doi: 10.1002/ 1099-1387(200010)6:10<497::AID-PSC277>3.0.CO;2-W
27. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN (1993) Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. J Natl Cancer Inst 85:971-978. doi: 10.1093/jnci/85.12.971
28. Licato LL, Keku TO, Wurzelmann JI, Murray SC, Woosley JT, Sandler RS, Brenner DA (1997) In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. Gastroenterology 113:1589-1598. doi: 10.1053/gast.1997.v113.pm9352861
29. Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180
30. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869
31. D'Abaco GM, Hooper S, Paterson H, Marshall CJ (2002) Loss of Rb overrides the requirement for ERK activity for cell proliferation. J Cell Sci 115:4607-4616. doi: 10.1242/jcs.00161
32. Cip/WAF1 and inhibits proliferation of colorectal cancer cells. Br J Pharmacol 137:597-607. doi: 10.1038/sj.bjp.0704909
33. Archer SY, Meng S, Shei A, Hodin RA (1998) p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791-6796. doi: 10.1073/pnas.95.12.6791
34. Nicholson DW, Thornberry NA (1997) Caspases: Killer protease. Trends Biochem Sci 22:299-306. doi: 10.1016/S0968-0004(97)01085-2
35. Barnes PJ, Karin M (1997) Nuclear factor-kappa B: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071. doi: 10.1056/NEJM199704103361506
36. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM, MacKay S (2000) Nuclear factor-kB is upregulated in colorectal cancer. Surgery 130:363-369. doi: 10.1067/msy.2001.116672
37. Joshi SG, Francis CW, Silverman DJ, Sahni SK (2003) Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity. Infect Immun 71:4127-4136. doi: 10.1128/IAI.71.7.4127-4136.2003
38. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815. doi: 10.1038/sj.onc.1204252
39. Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7-G17. doi: 10.1152/ajpgi.00079.2004
40. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54:5527-5530
41. Surh YJ, Kundu JK, Na HK, Lee JS (2005) Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 135:2993S-3001S
42. Rahman I, Marwick J, Kirkham P (2004) Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68:1255-1267. doi: 10.1016/j.bcp.2004.05.042
43. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867. doi: 10.1038/nature01322
44. Philip M, Rowley DA, Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433-439. doi: 10.1016/ j.semcancer.2004.06.006
45. Crowell JA, Steele VE, Sigman CC, Fay JR (2003) Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2:815-823
46. Hinz B, Brune K (2002) Cyclooxygenase-2-10 years later. J Pharmacol Exp Ther 300:367-375. doi: 10.1124/jpet.300.2.367
47. Scheller J, Ohnesorge N, Rose-John S (2006) Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63:321-329. doi: 10.1111/j.1365-3083.2006.01750.x
48. Seril DN, Liao J, Yang GY, Yang CS (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models. Carcinogenesis 24:353-362. doi: 10.1093/carcin/24.3.353
49. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481:243-268. doi: 10.1016/S0027-5107(01)00183-X
50. Bachschmid M, Schildknecht S, Ullrich V (2005) Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system. Biochem Biophys Res Commun 338:536-542. doi: 10.1016/j.bbrc.2005.08.157
51. Nair J, Barbin A, Velic I, Bartsch H (2000) Etheno DNA-base adducts from endogenous reactive species. Mutat Res 424:59-69. doi: 10.1016/ S0027-5107(99)00008-1
52. Naziroglu M, Cay M, Ustundag B, Aksakal M, Yekeler H (1999) Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct 17:253-259. doi: 10.1002/ (SICI)1099-0844(199912)17:4<253::AID-CBF837>3.0.CO;2-R